Dr. Maxwell Lloyd shared the importance of improving patient access to innovative therapies like Orserdu at the 2024 San Antonio Breast Cancer Symposium.

IntroductionThe global cancer therapeutics market is on an exponential growth trajectory, driven by advancements in treatment ...

Hundreds of FDA-approved drugs tested directly on a patient’s tumor sample. Could this be a gamechanger for cancer management ...

The Breast Reconstruction Market has witnessed remarkable advancements in recent years, driven by medical innovations, a ...

The $30 million facility was made possible, in part, through a $4 million contribution through the AdventHealth Palm Coast Foundation and its donors.

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

“We are living in the dark ages,” said Robyn Spoon, a member of the coalition and CEO of Elevate Childhood Cancer Research ...

In April 2023, Avacta Group dosed the first subject in the dose-escalation portion of its Phase I trial of AVA6000 in the US, ...

Information on tumor mutational status was limited before the development of NGS because traditional Sanger sequencing and ...

Experts reveal why cancer is surging more in women than menThe face of cancer in the US is shifting from older to younger ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

Surgery is the gold standard, GLP-1s are all the rage—whether a head-to-head study is needed depends on who you ask.